Androgen deprivation therapy for prostate cancer induces the metabolic syndrome: is it preventable?

被引：0
|
作者：
Nobes, J. P. [1 ]
Laing, R. W. [1 ]
Langley, S. E. M. [1 ]
机构：
[1] St Lukes Canc Ctr, Guildford, Surrey, England
来源：
BJU INTERNATIONAL | 2009年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] Complications of androgen deprivation therapy for prostate cancer
    Holzbeierlein, JM
    McLaughlin, MD
    Thrasher, JB
    CURRENT OPINION IN UROLOGY, 2004, 14 (03) : 177 - 183
  • [42] Androgen deprivation therapy for prostate cancer: An overview
    Rabbani, F
    Fair, WR
    INFECTIONS IN UROLOGY, 1999, 12 (03): : 69 - 74
  • [43] Advances with androgen deprivation therapy for prostate cancer
    Yu, Eun-mi
    Aragon-Ching, Jeanny B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (09) : 1015 - 1033
  • [44] ANDROGEN DEPRIVATION THERAPY INDUCES UNIQUE ANTI-WARBURG METABOLIC ALTERATION IN HORMONE SENSITIVE PROSTATE CANCER CELLS
    Khemees, Tariq A.
    Filon, Mikolaj
    Yang, Bing
    Gillette, Amani
    Gawdzik, Joseph
    Showalter, Megan
    Fiehn, Oliver
    Skala, Melissa
    Jarrard, David F.
    JOURNAL OF UROLOGY, 2020, 203 : E767 - E768
  • [45] Association of metabolic syndrome with reduced survival among men receiving androgen deprivation therapy for nonmetastatic prostate cancer
    Rudman, Sarah Maria
    Gray, Kathryn P.
    Kasperzyk, Julie
    Pitt, Michael
    Giovannucci, Edward
    Loda, Massimo
    Mucci, Lorelei
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [46] Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease A Review
    Collier, Andrew
    Ghosh, Sujoy
    McGlynn, Brian
    Hollins, Graham
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (05): : 504 - 509
  • [47] Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
    Namiki, Mikio
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Koh, Eitetsu
    JOURNAL OF MENS HEALTH, 2008, 5 (04) : 333 - 341
  • [48] Metabolic syndrome and insulin resistance in patients with prostate cancer treated with androgen deprivation hormone
    Terrier, J. -E.
    Mottet, N.
    PROGRES EN UROLOGIE, 2013, 23 (02): : 88 - 95
  • [49] Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications
    Vasileios Tzortzis
    Michael Samarinas
    Ioannis Zachos
    Athanasios Oeconomou
    Louis L. Pisters
    Alexandra Bargiota
    Hormones, 2017, 16 : 115 - 123
  • [50] IMPACT OF METABOLIC DISEASES AND DRUGS ON PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY
    Geng, Jiun-Hung
    Pomerantz, Mark
    Penney, Kathryn
    Nabi, Junaid
    Sweeney, Christopher
    Mucci, Lorelei
    Kibel, Adam
    JOURNAL OF UROLOGY, 2020, 203 : E1222 - E1223
12345